Matt Wolsfeld
Analyst · Axiom Capital. Your line is open
Thanks, Patrick. Sales of NTIC's ZERUST products increased across all market segments during the six months ended February 28, 2015, compared to the same period in fiscal 2014. Sales of industrial ZERUST corrosion inhibiting products increased over 6% as we experienced increased demand from both existing and new customers. Sales of ZERUST Oil & Gas solutions increased almost 11% in the first half of 2015 as we completed implementation of multiple new and existing customer sites in North America. Sales of ZERUST corrosion inhibiting products to our joint ventures increased over 5% during the six months ended February 28, 2015, compared to the prior fiscal year period. Income provided by our joint venture operations decreased by over 11% to $6.2 million during the first half of fiscal 2015 compared to the prior fiscal year period. However, that was mostly attributable to the termination of our joint venture agreement with Tianjin Zerust, our former joint venture in China, as previously discussed. Lastly, sales of Natur-Tec products increased over 56% to almost $2 million during the first half of fiscal '15 compared to the same period in fiscal 2014. Our total operating expenses increased over 9% to $8.9 million during the first half of fiscal 2015, compared to the prior fiscal year period, primarily due to an increase in selling, general and administrative expenses, and expenses incurred in support of joint ventures, which was previously mentioned were related primarily to the change in our Chinese operation. Overall, net income attributable to NTIC decreased 53% to $879,000, or $0.19 per diluted common share for the six months ended February 28, 2015, compared to $0.41 to the prior fiscal year period. As of February 28, 2015, our working capital was $17.8 million, including $3.4 million in cash and cash equivalents and $3.5 million in available for sale securities, compared to $17.8 million, including $2.5 million in cash and cash equivalents and $5.5 million in available for sale securities as of August 31, 2014. Now turning to NTIC's annual guidance. For the fiscal year ending August 31, 2015, we continue to expect our sales to be in the estimated range of $32 million to $34 million. However, there's still significant uncertainties in this estimate due to the recent information and establishment of NTIC China. We anticipate that we will be in a position to better update our net sales guidance after the third quarter of fiscal 2015. We expect net income of between $2.8 million and $3.1 million, or between $0.62 and $0.68 per diluted share. But this estimate is also subject to significant uncertainties relating to our new operations in China. With that update, I will now -- we will now answer any questions you may have.